Tokyo, Oct. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063348) titled 'Comparative efficacy and safety of first-line treatments for advanced EGFR exon 20 insertion-mutated non-small-cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials' on Oct. 20.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - Unresectable locally advanced or metastatic non-small-cell lung cancer harboring EGFR exon 20 insertion mutations
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To compare the efficacy and safety of first-line targeted monotherapy ...